GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Avricore Health Inc (TSXV:AVCR) » Definitions » Median PS Value

Avricore Health (TSXV:AVCR) Median PS Value : C$0.00 (As of Apr. 26, 2025)


View and export this data going back to 2001. Start your Free Trial

What is Avricore Health Median PS Value?

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Avricore Health's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 was C$0.047. Avricore Health's 10-Year median PS Ratio is 0. Therefore, the Median PS Value for today is C$0.00.

As of today (2025-04-26), Avricore Health's share price is C$0.055. Avricore Health's Median PS Value is C$0.00. Therefore, Avricore Health's Price to Median PS Value for today is 0.00.

The historical rank and industry rank for Avricore Health's Median PS Value or its related term are showing as below:

TSXV:AVCR's Price-to-Median-PS-Value is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 0.835
* Ranked among companies with meaningful Price-to-Median-PS-Value only.

Avricore Health Median PS Value Historical Data

The historical data trend for Avricore Health's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avricore Health Median PS Value Chart

Avricore Health Annual Data
Trend Jun14 Jun15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Median PS Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Avricore Health Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Median PS Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Avricore Health's Median PS Value

For the Diagnostics & Research subindustry, Avricore Health's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Avricore Health's Price-to-Median-PS-Value Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Avricore Health's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where Avricore Health's Price-to-Median-PS-Value falls into.


;
;

Avricore Health Median PS Value Calculation

Avricore Health's Median PS Value for today is calculated as

Median PS Value=Revenue per Share (TTM)*10-Year Median PS Ratio
=0.047*0
=0.00

10-Year Median PS Ratio is 0.
Avricore Health's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.047.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Avricore Health  (TSXV:AVCR) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

Avricore Health's Price to Median PS Value for today is calculated as

Price to Median PS Value=Share Price/Median PS Value
=0.055/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Avricore Health Median PS Value Related Terms

Thank you for viewing the detailed overview of Avricore Health's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Avricore Health Business Description

Traded in Other Exchanges
Address
1120 - 789 West Pender Street, Vancouver, BC, CAN, V6C 1H2
Avricore Health Inc is a Canada-based company. The company is involved in the business of health data and point-of-care technologies. The Company has only one segment, being the HealthTab - Point of Care Business in Canada. The Company's revenues are generated from operating leases of the POCT system and the sale of testing panels.
Executives
Kiriaki Smith Senior Officer
Rodger Mckendry Seccombe Senior Officer
Alan Arnstein Director
David Farnfield Director
David M. Hall Director
Inc. Emerald Health Therapeutics 10% Security Holder
Sukhwinder Singh Rai Director

Avricore Health Headlines

No Headlines